Induction of tumor necrosis factor-? as a cause of bleomycin-related toxicity

This publication has 21 references indexed in Scilit:

• High plasma tumor necrosis factor (TNF)-alpha concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-alpha, interferon-gamma, and melphalan
  Critical Care Medicine, 1996
• Increased expression of transforming growth factor beta isoforms (beta 1, beta 2, beta 3) in bleomycin-induced pulmonary fibrosis.
  American Journal of Respiratory Cell and Molecular Biology, 1995
• Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect
  British Journal of Cancer, 1995
• Phase II Trial of Recombinant Interleukin-1β in Patients with Metastatic Renal Cell Carcinoma
  Journal of Immunotherapy, 1994
• Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia
  Blood, 1994
• Lung Cytokine Production in Bleomycin-Induced Pulmonary Fibrosis
  Experimental Lung Research, 1992
• Fulminant hyperpyrexia induced by bleomycin
  Published by Oxford University Press (OUP) ,1989
• Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study
  JNCI Journal of the National Cancer Institute, 1988
• A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients.
  Journal of Clinical Oncology, 1988
• Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide
  New England Journal of Medicine, 1987